Market Overview:
The global drugs for sinusitis market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of sinusitis, rising awareness about available treatment options, and growing demand for minimally invasive procedures. The antibiotics segment is expected to account for the largest share of the global drugs for sinusitis market in 2018. This segment is projected to grow at a CAGR of 5.9% during the forecast period from 2018 to 2030. The corticosteroids segment is projected to grow at a CAGR of 6% during the same period owing to its high efficacy in treating chronic sinusitis and other associated symptoms such as inflammation and swelling. In terms of application, acute sinusitis accounted for the majority share of the global drugs for sinusitis market in 2017 and this trend is expected continue throughoutthe forecast period from2018to2030 ..
Product Definition:
A drug is a substance that alters the way the body works. Drugs for sinusitis are used to treat the infection and inflammation of the sinuses. They help reduce symptoms such as congestion, headache, and facial pain.
Antibiotics:
Antibiotics Market is expected to grow at a CAGR of XX% during the forecast period. The market growth can be attributed to factors such as increasing geriatric population, rising prevalence of bacterial infections and growing demand for effective treatment options. Sinusitis is one of the most common conditions treated with antibiotics worldwide. According to CDC, in 2016, more than 20 million people in U.
Corticosteroids:
Corticosteroids are the group of drugs which acts by reducing the inflammation in body. It works by decreasing cytokines and prostaglandins which causes inflammation. Corticosteroid is used for treatment of asthma, rheumatoid arthritis, Crohn's disease, ulcerative colitis and multiple sclerosis.
Application Insights:
The acute sinusitis segment dominated the global drugs for sinusitis market in 2017. The segment is expected to witness a CAGR of XX% over the forecast period owing to an increase in the number of patients suffering from acute rhinosinusitis. According to a study published by NCBI, it was observed that approximately 1-2% of total population get affected by acute rhinosinusitis every year and around 50-100 million people suffer from this condition globally.
Chronic sinusitis application is anticipated to witness significant growth during the forecast period due largely on increasing prevalence rate and technological advancements in diagnostics procedures related to chronicsinusitisa nd other nasal diseases such as allergic rhinopathy, nasal congestion or runny nose among children & adolescents along with rising healthcare costs associated with these disorders which eventually boosts demand for effective treatment options leadingto increased usageof medicines such as antibiotics.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing prevalence of acute and chronic sinusitis, growing geriatric population, and rising healthcare expenditure. In addition, introduction of new products boosting sales in this region is also one of the key reasons responsible for regional growth. For instance, in May 2018 Fycompa was launched by Teva Pharmaceuticals USA Inc.; it is a once-daily oral antibiotic indicated for treatment of bacterial infections due to SINUS INFECTIONS (acute or chronic) caused by susceptible strains of Staphylococcus aureus or Streptococcus pneumoniae.
Asia Pacific market was valued at USD X million in 2017.
Growth Factors:
- Increasing incidence of sinusitis
- Growing awareness about the benefits of drugs for sinusitis treatment
- Rising demand for minimally invasive procedures for sinusitis treatment
- Technological advancements in drug delivery systems for sinusitis treatment
- Growing number of clinical studies on new drugs for sinusitis
Scope Of The Report
Report Attributes
Report Details
Report Title
Drugs for Sinusitis Market Research Report
By Type
Antibiotics, Corticosteroids, Decongestants
By Application
Acute Sinusitis, Chronic Sinusitis
By Companies
Sanofi, Bayer AG, Pfizer, AstraZeneca Plc, Novartis AG., Johnson & Johnson, Merck, Amgen, Bionorica SE, Dr. Reddy's Laboratories, Huasun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Drugs for Sinusitis Market Report Segments:
The global Drugs for Sinusitis market is segmented on the basis of:
Types
Antibiotics, Corticosteroids, Decongestants
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Acute Sinusitis, Chronic Sinusitis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Bayer AG
- Pfizer
- AstraZeneca Plc
- Novartis AG.
- Johnson & Johnson
- Merck
- Amgen
- Bionorica SE
- Dr. Reddy's Laboratories
- Huasun
Highlights of The Drugs for Sinusitis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Corticosteroids
- Decongestants
- By Application:
- Acute Sinusitis
- Chronic Sinusitis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drugs for Sinusitis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one answer to this question as the best drugs for sinusitis will vary depending on the individual's symptoms and medical history. However, some common medications used to treat sinusitis include antibiotics, over-the-counter painkillers, and nasal sprays.
Some of the major companies in the drugs for sinusitis market are Sanofi, Bayer AG, Pfizer, AstraZeneca Plc, Novartis AG., Johnson & Johnson, Merck, Amgen, Bionorica SE, Dr. Reddy's Laboratories, Huasun.
The drugs for sinusitis market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drugs for Sinusitis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drugs for Sinusitis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drugs for Sinusitis Market - Supply Chain
4.5. Global Drugs for Sinusitis Market Forecast
4.5.1. Drugs for Sinusitis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drugs for Sinusitis Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drugs for Sinusitis Market Absolute $ Opportunity
5. Global Drugs for Sinusitis Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drugs for Sinusitis Market Size and Volume Forecast by Type
5.3.1. Antibiotics
5.3.2. Corticosteroids
5.3.3. Decongestants
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drugs for Sinusitis Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drugs for Sinusitis Market Size and Volume Forecast by Application
6.3.1. Acute Sinusitis
6.3.2. Chronic Sinusitis
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drugs for Sinusitis Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drugs for Sinusitis Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drugs for Sinusitis Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drugs for Sinusitis Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drugs for Sinusitis Demand Share Forecast, 2019-2029
9. North America Drugs for Sinusitis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drugs for Sinusitis Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drugs for Sinusitis Market Size and Volume Forecast by Application
9.4.1. Acute Sinusitis
9.4.2. Chronic Sinusitis
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drugs for Sinusitis Market Size and Volume Forecast by Type
9.7.1. Antibiotics
9.7.2. Corticosteroids
9.7.3. Decongestants
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drugs for Sinusitis Demand Share Forecast, 2019-2029
10. Latin America Drugs for Sinusitis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drugs for Sinusitis Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drugs for Sinusitis Market Size and Volume Forecast by Application
10.4.1. Acute Sinusitis
10.4.2. Chronic Sinusitis
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drugs for Sinusitis Market Size and Volume Forecast by Type
10.7.1. Antibiotics
10.7.2. Corticosteroids
10.7.3. Decongestants
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drugs for Sinusitis Demand Share Forecast, 2019-2029
11. Europe Drugs for Sinusitis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drugs for Sinusitis Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drugs for Sinusitis Market Size and Volume Forecast by Application
11.4.1. Acute Sinusitis
11.4.2. Chronic Sinusitis
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drugs for Sinusitis Market Size and Volume Forecast by Type
11.7.1. Antibiotics
11.7.2. Corticosteroids
11.7.3. Decongestants
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drugs for Sinusitis Demand Share, 2019-2029
12. Asia Pacific Drugs for Sinusitis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drugs for Sinusitis Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drugs for Sinusitis Market Size and Volume Forecast by Application
12.4.1. Acute Sinusitis
12.4.2. Chronic Sinusitis
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drugs for Sinusitis Market Size and Volume Forecast by Type
12.7.1. Antibiotics
12.7.2. Corticosteroids
12.7.3. Decongestants
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drugs for Sinusitis Demand Share, 2019-2029
13. Middle East & Africa Drugs for Sinusitis Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drugs for Sinusitis Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drugs for Sinusitis Market Size and Volume Forecast by Application
13.4.1. Acute Sinusitis
13.4.2. Chronic Sinusitis
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drugs for Sinusitis Market Size and Volume Forecast by Type
13.7.1. Antibiotics
13.7.2. Corticosteroids
13.7.3. Decongestants
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drugs for Sinusitis Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Drugs for Sinusitis Market: Market Share Analysis
14.2. Drugs for Sinusitis Distributors and Customers
14.3. Drugs for Sinusitis Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sanofi
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer AG
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AstraZeneca Plc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novartis AG.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson & Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Merck
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Amgen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bionorica SE
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Dr. Reddy's Laboratories
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Huasun
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
